Altered apoptosis of inflammatory neutrophils in MMP-9-deficient mice is due to lower expression and activity of caspase-3

Immunology Letters

Volumn 126, Issue 1-2, 2009, Pages 73-82

  Kolaczkowska, Elzbieta ^a   Koziol, Agnieszka ^a   Plytycz, Barbara ^a   Arnold, Bernd ^b   Opdenakker, Ghislain ^c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Caspase 3; COX 1; Gelatinase B; Leukocytes; Matrix metalloproteinase 9; Peritoneal inflammation; Peritonitis

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYCLOOXYGENASE 1; GELATINASE B; PROSTAGLANDIN E2; PROTEIN BAX; PROTEIN BCL 2; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; LYMPHOCYTE; MALE; MAST CELL; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; NEUTROPHILS; PERITONITIS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRAZOLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ZYMOSAN;

EID: 70249085914     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.08.002     Document Type: Article

References (50)

1. Opdenakker G., Van den Steen P.E., Dubois B., Nelissen I., Van Coillie E., Masure S., et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69 (2001) 851-859
2. Kim J.H., Suk M.H., Yoon D.W., Lee S.H., Hur G.Y., Jung K.H., et al. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 291 (2006) L580-L587
3. Chakraborti S., Mandal M., Das S., Mandal A., and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253 (2003) 269-285
4. Opdenakker G., Van den Steen P.E., and Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol 22 (2001) 571-579
5. Parks W.C., Wilson C.L., and Lopez-Boado Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4 (2004) 617-629
6. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., and Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37 (2002) 375-536
7. Van Lint P., and Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 82 (2007) 1375-1381
8. Liu Z., Shipley J.M., Vu T.H., Zhou X., Diaz L.A., Werb Z., et al. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med 188 (1998) 475-482
9. D'Haese A., Wuyts A., Dillen C., Dubois B., Billiau A., Heremans H., et al. In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse. J Interferon Cytokine Res 20 (2000) 667-674
10. Hamada T., Fondevila C., Busuttil R.W., and Coito A.J. Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology 47 (2008) 186-198
11. Kolaczkowska E., Chadzinska M., Scislowska-Czarnecka A., Plytycz B., Opdenakker G., and Arnold B. Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis. Immunobiology 211 (2006) 137-148
12. 2 of macrophage origin. J Leukoc Biol 80 (2006) 125-132
13. Kolaczkowska E., Lelito M., Kozakiewicz E., van Rooijen N., Plytycz B., and Arnold B. Resident peritoneal leukocytes are important sources of MMP-9 during zymosan peritonitis: superior contribution of macrophages over mast cells. Immunol Lett 113 (2007) 99-106
14. Kolaczkowska E., Grzybek W., van Rooijen N., Piccard H., Plytycz B., Arnold B., et al. Neutrophil elastase activity compensates for a genetic lack of matrix metalloproteinase-9 (MMP-9) in leukocyte infiltration in a model of experimental peritonitis. J Leukoc Biol 85 (2009) 374-381
15. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93 (1998) 411-422
16. Vaillant C., Meissirel C., Mutin M., Belin M.F., Lund L.R., and Thomasset N. MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum. Mol Cell Neurosci 24 (2003) 395-408
17. Ovechkin A.V., Tyagi N., Rodriguez W.E., Hayden M.R., Moshal K.S., and Tyagi S.C. Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice. J Appl Physiol 99 (2005) 2398-2405
18. Chintala S.K., Zhang X., Austin J.S., and Fini M.E. Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem 277 (2002) 47461-47468
19. Haslett C., Guthrie L.A., Kopaniak M.M., Johnston Jr. R.B., and Henson P.M. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119 (1985) 101-110
20. Chowdhury I., Tharakan B., and Bhat G.K. Current concepts in apoptosis: the physiological suicide program revisited. Cell Mol Biol Lett 11 (2006) 506-525
21. Assuncao Guimaraes C., and Linden R. Programmed cell deaths. Apoptosis and alternative deathstyles. Eur J Biochem 271 (2004) 1638-1650
22. Chowdhury I., Tharakan B., and Bhat G.K. Caspases-an update. Comp Biochem Physiol B Biochem Mol Biol 151 (2008) 10-27
23. Yeretssian G., Labbe K., and Saleh M. Molecular regulation of inflammation and cell death. Cytokine 43 (2008) 380-390
24. Basak S., and Hoffmann A. Crosstalk via the NF-κB signaling system. Cytokine Growth Factor Rev 19 (2008) 187-197
25. Alexander W.S., and Hilton D.J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 22 (2004) 503-529
26. Miller S.B. Prostaglandins in health and disease: an overview. Semin Arthritis Rheum 36 (2006) 37-49
27. Barnes P.J. Nuclear factor-κB. Int J Biochem Cell Biol 29 (1997) 867-870
28. Poligone B., and Baldwin A.S. Positive and negative regulation of NF-κB by COX-2: roles of different prostaglandins. J Biol Chem 276 (2001) 38658-38664
29. Kolaczkowska E., Plytycz B., Arnold B., Piccard H., and Opdenakker G. Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9. Immunology 128 (2009) e262-e274
30. Dubois B., Masure S., Hurtenbach U., Paemen L., Heremans H., van den Oord J., et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest 104 (1999) 1507-1515
31. 2. Prostaglandins 30 (1985) 769-789
32. Kolaczkowska E., Seljelid R., and Plytycz B. Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice. J Leukoc Biol 69 (2001) 33-42
33. Baumgartner H.K., Kirbiyik U., Coskun T., Chu S., and Montrose M.H. Endogenous cyclo-oxygenase activity regulates mouse gastric surface pH. J Physiol 544 (2002) 871-882
34. Daley J.M., Thomay A.A., Connolly M.D., Reichner J.S., and Albina J.E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83 (2008) 64-70
35. Ho M.K., and Springer T.A. Tissue distribution, structural characterization, and biosynthesis of Mac-3, a macrophage surface glycoprotein exhibiting molecular weight heterogeneity. J Biol Chem 258 (1983) 636-642
36. Turchyn L.R., Baginski T.J., Renkiewicz R.R., Lesch C.A., and Mobley J.L. Phenotypic and functional analysis of murine resident and induced peritoneal macrophages. Comp Med 57 (2007) 574-580
37. Kolaczkowska E., Barteczko M., Plytycz B., and Arnold B. Role of lymphocytes in the course of murine zymosan-induced peritonitis. Inflamm Res 57 (2008) 272-278
38. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol 61 (1997) 375-380
39. Olle E.W., Ren X., McClintock S.D., Warner R.L., Deogracias M.P., Johnson K.J., et al. Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice. Hepatology 44 (2006) 540-549
40. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91 (1997) 439-442
41. Salamone G., Giordano M., Trevani A.S., Gamberale R., Vermeulen M., Schettinni J., et al. Promotion of neutrophil apoptosis by TNF-α. J Immunol 166 (2001) 3476-3483
42. Brune B., von Knethen A., and Sandau K.B. Nitric oxide (NO): an effector of apoptosis. Cell Death Differ 6 (1999) 969-975
43. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., et al. Cyclooxygenase in biology and disease. FASEB J 12 (1998) 1063-1073
44. 2 promoter-binding factor-1. Oncol Rep 20 (2008) 605-611
45. 2α in bovine luteal steroidogenic cells. Biol Reprod 79 (2008) 310-317
46. Cowland J.B., and Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leukoc Biol 66 (1999) 989-995
47. Nguyen M., Arkell J., and Jackson C.J. Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles. J Biol Chem 273 (1998) 5400-5404
48. Pereira A.M., Strasberg-Rieber M., and Rieber M. Invasion-associated MMP-2 and MMP-9 are up-regulated intracellularly in concert with apoptosis linked to melanoma cell detachment. Clin Exp Metastasis 22 (2005) 285-295
49. Stennicke H.R., and Salvesen G.S. Caspases-controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta 1477 (2000) 299-306
50. Kolaczkowska E., Arnold B., and Opdenakker G. Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils. Immunobiology 213 (2008) 109-124